Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

MIT McGovern Institute
mcgovern.mit.edu > 08/18/2026 > tackling-rare-genetic-disorders-with-patient-focused-science

Tackling rare genetic disorders with patient-focused science

41+ min ago   (643+ words) by Stefanie Koperniak | Office of Graduate Education | August 18, 2026August 18, 2026 Shannon Knight, a brain and cognitive sciences PhD candidate and McGovern Institute researcher, focuses on developing a novel gene therapy. Shannon Knight attributes her interest in neuroscience to an experience she had…...

MedPage Today
medpagetoday.com > opinion > second-opinions > 122651

Opinion | The Promise and Peril of Gene Editing

1+ hour, 49+ min ago   (714+ words) MedPage Today The Promise and Peril of Gene Editing — Ethical and regulatory guardrails must protect patients amid desperation and scientific optimism Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That…...

WVTM
wvtm13.com > article > alabama-child-hearing-loss-therapy > 73462006

ALL Kids helps Alabama child access gene therapy for rare hearing loss

1+ hour, 19+ min ago   (232+ words) Video above: Jason breaks down the scorching week ahead. An Alabama child enrolled in the ALL Kids program has become eligible to receive a newly approved gene therapy for a rare form of inherited deafness, the Alabama Department of Public…...

Oncodaily - Oncology News
oncodaily.com > new-paper-alert > marco-davila

Marco Davila: We Need to Do a Better Job Delivering CAR T to Patients - OncoDaily

20+ hour, 20+ min ago   (292+ words) Marco Davila, Senior Vice President of Translational Medicine at Roswell Park Comprehensive Cancer Center, shared on LinkedIn: “CAR T-cell therapy has delivered on its promise. Now we need to do a better job delivering CAR T to patients. When CAR…...

BioProcess International
bioprocessintl.com > personalized-medicine > cell-summit-2026-an-80-year-journey-to-stamping-out-leukemia

Sidney Farber's legacy lives on in CAR T therapy success

23+ hour ago   (824+ words) A professor from Cincinnati Children’s Hospital discussed how Sidney Farber’s legacy has led to lives being saved through cell-therapy innovations today. During the morning session of the Cell Summit in Cincinnati, Ohio, Stella Davies, professor of pediatric oncology at Cincinnati…...

Chemistry World
chemistryworld.com > news > step-forward-for-car-t-therapy-as-it-shows-promise-in-solid-bladder-tumours > 4024034.article

Step forward for CAR-T therapy as it shows promise in solid bladder tumours

1+ day, 2+ hour ago   (505+ words) Bladder tumour size is greatly reduced when CAR-T cells targeting MUC16 are delivered directly to the bladder via a catheter (right two panels) Genetically engineered T cells derived from patients have been developed to recognise and destroy human-derived bladder tumours in…...

Oncodaily - Oncology News
oncodaily.com > new-paper-alert > julia-carnevale-567418

Julia Carnevale: Targeting P2RY8 and GNAS to Enhance T Cell Therapy in Solid Tumors - OncoDaily

2+ day, 1+ hour ago   (559+ words) Julia Carnevale, Assistant Professor at the Gladstone-UCSF Institute of Genomic Immunology, shared on X: “Incredibly excited to share the first major paper from my lab Carnevale Lab led by postdoc Qi Liu Gladstone Institutes UCSF executing the first ever genome-wide in…...

Oncodaily - Oncology News
oncodaily.com > voices > lurie-cancer-center-566745

Five-Year Results Highlight the Long-Term Promise of CAR T-Cell Therapy in Aggressive Blood Cancers - Lurie Cancer Center - OncoDaily

3+ day, 5+ hour ago   (83+ words) Lurie Cancer Center shared a post on X: “New five-year results highlight the long-term promise of CAR T Cell Therapy for patients with relapsed or refractory large B Cell Lymphoma. Researchers found durable survival outcomes, further supporting the role of Cellular…...

The West Australian
thewest.com.au > news > health > personalised-medicine-centres-funding-boost-aims-to-help-treat-rare-diseases-for-troopers-like-mina-hille-c-22693910

Perth lab to lead the nation in gene-patching technology

3+ day, 3+ hour ago   (609+ words) Perth will be home to a national centre to develop a personalised medicine known as gene-patching, which treats rare diseases by targeting the specific genetic defects within an individual....

Google News
ksla.com > 08/15/2026 > north-louisiana-woman-credits-rare-car-t-cell-therapy-with-putting-her-cancer-remission

North Louisiana woman credits rare CAR T-cell therapy with putting her cancer in remission

3+ day, 15+ hour ago   (936+ words) SHREVEPORT, La. (KSLA) - A North Louisiana woman says a rare cancer treatment gave her a second chance after years of searching for answers. Martha Durden-Scroggins was diagnosed with B-cell lymphoma at age 68 — a disease where white blood cells slowly grow…...